November 3, 2009 - Elekta presented new tools for improved clinical precision, workflow efficiency and patient comfort, including Intuity*and Symmetry* advanced image-guidance solutions at the 51st Annual Meeting of the American Society for Radiation Oncology (ASTRO), in Chicago, Ill.

Some of the new tools include:

• Intuity, Elekta’s next release of IGRT software, will allow clinicians to understand continuous changes in the positional relationships of both tumor and healthy tissues at the time of treatment. For the first time, this innovation will allow accurate patient repositioning to ensure target coverage without inadvertently placing organs at risk into the beam path.

• Symmetry will be the next generation of image guidance, creating new solutions for motion management. This patented innovation will allow clinicians to quantify the set-up changes required to accommodate ‘baseline shifts’ (tumor path changes between treatments). Symmetry’s use of anatomically correlated guidance is an alternative to gating and offers significantly shorter treatment times with less set-up complexity.

• In celebrating the production of their 2,000th digital linear accelerator, Elekta unveiled a sixth-generation digital treatment control system, Integrity**. Taking advantage of a complete re-engineering into the LynX OS platform, Integrity adds to its reputation for efficiency and reliability; MLC interdigitation, continuously variable dose rate for VMAT and enhanced virus protection.

• Elekta Infinity, a premier digital linear accelerator optimized for Volumetric Modulated Arc Therapy (VMAT). With its multi-arcing capabilities, Infinity delivers high dose conformance, treatment speed and ultra-low dose safeguards and allows personalization of imaging and treatment workflows.

• MOSAIQ 2.0, a comprehensive oncology charting solution that increases productivity, elevates efficiency and facilitates high-quality patient care. Complete with new connectivity, new functions and database enhancements, while preserving the user interface, MOSAIQ supports the entire cancer team by uniting diverse systems and devices.

• Monaco with VMAT, a next generation IMRT treatment planning system that helps make the planning process easier, more straightforward and clinically reliable. With reduced planning time and increased clinical throughput, Monaco with VMAT optimizes single or multiple non-coplanar arcs simultaneously, providing the flexibility and control needed for complex treatment plans.

• Extend, a stereotactic treatment program that lets neurosurgeons and radiation oncologists apply the power and precision of Gamma Knife surgery to a broader class of targets in the head and neck. Now available in the United States, Extend for Leksell Gamma Knife Perfexion includes a re-locatable frame and support for fractionated treatments, which provides cross functional advantages in stereotactic radiosurgery and stereotactic radiotherapy for neurosurgeons and radiation oncologists.

Elekta also presented new independent clinical research discussing the advantages of stereotactic radiosurgery for treating of multiple brain metastases in comparison to whole brain radiation therapy.

For a complete speaker schedule: www.elekta.com/astro_presentations

*Intuity and Symmetry are feature sets of XVI 4.5, works in progress requiring a 510(k) review and not yet available in the U.S.

**Integrity is a works in progress requiring 510(k) review and not yet available in the U.S.


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Radiation Oncology

July 9, 2024 — Insights from the latest Mordor Intelligence report, “Radiotherapy Market Size & Share Analysis - Growth ...

Time July 09, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Radiology Business

July 3, 2024 — The American Society of Radiologic Technologists has launched the BeRAD Professionalism Award to ...

Time July 03, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now